JPRN-UMIN000013289尚未招募1 期
A Phase I Study of the WT1 peptide vaccine for the post-transplant AML at 2nd remission - A Phase I Study of the WT1 peptide vaccine for the post-transplant AM Lat 2nd remission
Osaka University Graduate school of medicine, Pediatrics0 个研究点目标入组 24 人开始时间: 2014年4月1日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 20years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with Down syndrome 2.Patients who relapsed less than 6 months after the end of initial therapy 3.Patients who suffered from uncontrollable infection and organ failure 4.Patients who suffered from active GVHD
研究者
相似试验
已完成
1 期
Phase I clinical trial of WT1 peptide-based vaccine for the HLA-A*0201 positive patients with malignant tumors.Malignant solid tumors, Malignant lymphoma, Multiple Myeloma, Acute leukemiaJPRN-UMIN000000933Department of Cancer immunotherapy, Osaka University Medical School10
已完成
1 期
Phase I clinical trial of WT1 peptide-based vaccine combined with Temozoromide for patients with malignant glioma.Malignant GliomaJPRN-UMIN000003504Department of Cancer immunotherapy, Osaka University Graduate School of Medicine3
尚未招募
不适用
Phase I clinical trial of WT1 peptide-based vaccine combined with Temozoromide for pediatric patients with malignant glioma.High grade glioma, Diffuse intrinsic pontine gliomaJPRN-UMIN000013257Osaka University Graduate School of Medicine Pediatrics18
已完成
1 期
Phase I clinical trial of WT1 peptide vaccine therapy for pediatric cancersPediatric cancersJPRN-UMIN000011030Shinshu University15
已完成
1 期
Phase I/II clinical trial of WT1 peptide vaccine therapy for lung, breast, pancreas, stomach, and colorectal cancerung, breast, pancreas, stomach, and colorectal cancerJPRN-UMIN000011029Shinshu University50